Lincoln National Corp Vivos Therapeutics, Inc. Transaction History

Lincoln National Corp

  • $3.11 Billion
  • Q3 2024

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 07, 2023
BUY
$0.35 - $20.75 $5,185 - $307,452
14,817 New
14,817 $5,000

About Vivos Therapeutics, Inc.

VVOS Quotes by TradingView
  • Ticker VVOS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 23,012,100
  • Market Cap $78.2M
  • Description
  • Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers the Vivos System, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dent...
More about VVOS
Track This Portfolio

Track Lincoln National Corp Portfolio

Follow Lincoln National Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lincoln National Corp, based on Form 13F filings with the SEC.

News

Stay updated on Lincoln National Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email